Summary of the technology
Using Peptide Nucleic Acids (PNAs) as a Tool to Diagnose COVID-19
We offer a fast and efficient diagnostic method which can be applied to a large amount of tests in a short time.
Our method is based on a kit which identifies specifically the viral RNA biomarker.
The test is characterized by reliability, sensitivity, rapid (not more than 10-15 minutes), low toxicity and reasonable cost.
Project ID : 47-2020-10881
Description of the technology
- We offer a fast and efficient diagnostic method which can be applied to a large amount of tests in a short time.
- Our method is based on a kit which identifies specifically the viral RNA biomarker.
- The test is characterized by reliability, sensitivity, rapid (not more than 10-15 minutes), low toxicity and reasonable cost.
Project manager
Keren-Or Amar
VP, Business Development, Healthcare
Project researchers
Eylon Yavin
HUJI, School of Medicine - IMRIC
School of Pharmacy- Institute for Drug Research
Related Keywords